Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

被引:29
作者
Burguera, B. [1 ]
Agusti, A. [3 ]
Arner, P. [4 ]
Baltasar, A. [5 ]
Barbe, F. [6 ]
Barcelo, A. [7 ]
Breton, I. [8 ]
Cabanes, T. [9 ]
Casanueva, F. F. [10 ]
Couce, M. E. [11 ]
Dieguez, C. [12 ]
Fiol, M. [13 ]
Fernandez Real, J. M. [14 ]
Formiguera, X. [15 ]
Fruhbeck, G. [16 ]
Romero, M. Garcia [28 ]
Sanz, M. Garcia [17 ]
Ghigo, E. [18 ]
Gomis, R. [19 ]
Higa, K. [20 ]
Ibarra, O. [21 ]
Lacy, A. [22 ]
Larrad, A. [23 ]
Masmiquel, L. [24 ]
Moize, V. [25 ]
Moreno, B. [26 ]
Moreiro, J.
Ricart, W. [27 ]
Riesco, R.
Salinas, M.
Salvador, J.
Pi-Sunyer, F. X. [29 ]
Scopinaro, N. [30 ]
Sjostrom, L.
Pagan, A.
Pereg, V.
Sanchez Pernaute, A.
Torres, A. [2 ]
Urgeles, J. R.
Vidal-Puig, A. [31 ]
Vidal, J.
Vila, M.
机构
[1] Hosp Univ Son Dureta, Res Unit, Serv Endocrinol, IUNICS, Palma de Mallorca 07014, Spain
[2] Univ Complutense, Dept Surg, Hosp Clin San Carlos, E-28040 Madrid, Spain
[3] Hosp Univ Son Dureta, Pulm Serv, Mallorca, Spain
[4] Karolinska Inst, Dept Med, Huddinge, Sweden
[5] Hosp Alcoy, Dept Surg, Alicante, Spain
[6] Hosp Vilanova Arnau, Pulm Serv, Lerida, Spain
[7] Hosp Univ Son Dureta, Lab Med, Mallorca, Spain
[8] Hosp Gen Gregorio Maranon, Dept Nutr, Madrid, Spain
[9] Inst Serv Sociales & Deport Consejo Insular Palma, Santiago, Spain
[10] Univ Santiago, Serv Endocrinol, Santiago, Spain
[11] Hosp Univ Son Dureta, Pathol Serv, Mallorca, Spain
[12] Univ Santiago, Dept Physiol, Santiago, Spain
[13] Hosp Univ Son Dureta, Coronary Care Unit, Mallorca, Spain
[14] Hosp Girona Dr Josep Trueta, Serv Endocrinol, Girona, Spain
[15] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[16] Univ Navarra Clin, Serv Endocrinol, Pamplona, Spain
[17] Hosp Univ Son Dureta, Surg Serv, Mallorca, Spain
[18] Univ Turin, Dept Endocrinol, Turin, Italy
[19] Hosp Clin Barcelona, Serv Endocrinol, Barcelona, Spain
[20] Univ Calif San Francisco, San Francisco, CA 94143 USA
[21] Hosp Univ Son Dureta, Psychiat Serv, Mallorca, Spain
[22] Hosp Clin Barcelona, Surg Serv, Barcelona, Spain
[23] Ruber Clin, Madrid, Spain
[24] Hosp Son Llatzer, Serv Endocrinol, Mallorca, Spain
[25] Hosp Clin Barcelona, Nutr Serv, Barcelona, Spain
[26] Hosp Univ Gregorio Maranon, Obes Unit, Madrid, Spain
[27] Hosp Girona Dr Josep Trueta, Serv Endocrinol, Girona, Spain
[28] Hosp Univ Son Dureta, Anesthesia Serv, Mallorca, Spain
[29] Columbia Univ, Dept Med, New York, NY USA
[30] Univ Genoa, Dept Surg, Genoa, Italy
[31] Univ Cambridge, Cambridge, England
基金
英国医学研究理事会;
关键词
morbid obesity; bariatric surgery; gastric bypass surgery; biliopancretic diversion; ghrelin; medical therapy;
D O I
10.1007/BF03349226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An interdisciplinary panel of specialists met in Mallorca in the first European Symposium on Morbid Obesity entitled; '' Morbid Obesity, an Interdisciplinary Approach ''. During the two and half days of the meeting, the participants discussed several aspects related to pathogenesis, evaluation, and treatment of morbid obesity. The expert panel included basic research scientists, dietitians and nutritionists, exercise physiologists, endocrinologists, psychiatrists, cardiologists, pneumonologists, anesthesiologists, and bariatric surgeons with expertise in the different weight loss surgeries. The symposium was sponsored by the Balearic Islands Health Department; however, this statement is an independent report of the panel and is not a policy statement of any of the sponsors or endorsers of the Symposium. The prevalence of morbid obesity, the most severe state of the disease, has become epidemic. The current recommendations for the therapy of the morbidly obese comes as a result of a National Institutes of Health (NIH) Consensus Conference held in 1991 and subsequently reviewed in 2004 by the American Society for Bariatric Surgery. This document reviews the work-up evaluation of the morbidly obese patient, the current status of the indications for bariatric surgery and which type of procedure should be recommended; it also brings up for discussion some important real-life clinical practice issues, which should be taken into consideration when evaluating and treating morbidly obese patients. Finally, it also goes through current scientific evidence supporting the potential effectiveness of medical therapy as treatment of patients with morbid obesity.
引用
收藏
页码:844 / 852
页数:9
相关论文
共 41 条
[1]   Prevalence of obesity in Spain [J].
Aranceta-Bartrina, J ;
Serra-Majern, L ;
Foz-Sala, M ;
Moreno-Esteban, B .
MEDICINA CLINICA, 2005, 125 (12) :460-466
[2]   The efficacy and safety of sibutramine for weight loss - A systematic review [J].
Arterburn, DE ;
Crane, PK ;
Veenstra, DL .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :994-1003
[3]   Bariatric surgery for morbid obesity: Health implications for patients, health professionals and third-party payers [J].
Buchwald, H .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (04) :593-604
[4]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[5]   Morbid obesity and the transition from welfare to work [J].
Cawley, J ;
Danziger, S .
JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2005, 24 (04) :727-743
[6]  
Cook CM, 1999, OBES SURG, V9, P80
[7]   Is ghrelin the culprit for weight loss gastric bypass surgery? A negative answer [J].
Couce, Marta E. ;
Cottam, Daniel ;
Esplen, James ;
Schauer, Phillip ;
Burguera, Bartolome .
OBESITY SURGERY, 2006, 16 (07) :870-878
[8]   Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. [J].
Cummings, DE ;
Weigle, DS ;
Frayo, RS ;
Breen, PA ;
Ma, MK ;
Dellinger, EP ;
Purnell, JQ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1623-1630
[9]  
*DEP HLTH, 2001, HLTH SURV ENGL
[10]   Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects [J].
Faraj, M ;
Havel, PJ ;
Phélis, S ;
Blank, D ;
Sniderman, AD ;
Cianflone, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1594-1602